News
News
News

Home > Activities & Acquisitions > News > NCC Innovative - NCC Recognized as National AI Medical Device Innovation Leader, Selected for Prestigious "Strive for Excellence" Program

NCC Innovative - NCC Recognized as National AI Medical Device Innovation Leader, Selected for Prestigious "Strive for Excellence" Program

Time: Dec 09,2025 Source: Click count: 7
ABSTRACT
SHANGHAI, December 8, 2025 – NCC MEDICAL Group today announced its successful selection for the highly competitive 2025 AI Medical Device Innovation "Strive for Excellence" Program (揭榜挂帅), jointly administered by the Department of Science and Technology of the Ministry of Industry and Information Technology (MIIT) and the Medical Device Registration Department of the National Medical Products Administration(NMPA).




     This national recognition underscores NCC MEDICAL’s cutting-edge capabilities in the intelligent healthcare sector, specifically highlighting its proprietary technology: Smart Wireless Multi-Channel Sleep Monitoring System Based on Flexible Sensing and Multi-Modal Collaboration. NCC MEDICAL stands out as one of the leading enterprises nationwide in the critical area of Intelligent Monitoring and Life Support Products.


Wireless Polysomnography Monitoring System



8-Channel EEG

Complies with the standards of the American Academy of Sleep Medicine (AASM) and the gold standard for sleep disorder assessment.

●13-Channel PSG: Eye Movement / Mental Electromyography (EMG) / Oronasal Airflow / Snoring Sound / Thoracic Respiration / Abdominal Respiration / Electrocardiography (ECG) / Blood Oxygen Saturation (SpO2) / Pulse Rate / Body Position / Limb Electromyography (EMG)



NCC Medical’s Breakthrough: Intelligent Sleep Monitoring


     The "Strive for Excellence" program is a flagship initiative designed to accelerate the deep integration of Artificial Intelligence into medical devices, focusing on breakthroughs in key core technologies and the independent innovation of high-end medical equipment. The program targets crucial areas such as Smart Auxiliary Decision-Making, Brain-Machine Hybrid Intelligence, and Intelligent Monitoring and Life Support, selecting organizations with exceptional R&D strength and strong potential for industrial commercialization to lead national research efforts.




     The selected project’s core output, the Smart Wireless Multi-Channel Sleep Monitoring System, represents a significant leap in diagnostics. It seamlessly integrates advanced flexible wearable sensing technology, multi-modal biosignal acquisition, and powerful AI algorithm analysis.

This innovative system achieves high-precision, non-intrusive ("no-sense"), and continuous monitoring of multi-dimensional physiological parameters, including:


Screening and Management of Sleep-Disordered Breathing: For high-risk groups such as those with Obstructive Sleep Apnea (OSA), it provides a more convenient and continuous closed-loop tool for screening-diagnosis-follow-up, improving the early identification rate and intervention effectiveness.

Cardio-Cerebral Comorbidity Risk Monitoring: In the sleep scenario, it simultaneously monitors arrhythmias and changes in sleep structure, provides continuous evidence for cardiovascular-sleep comorbidity management, and assists in clinical decision-making.

Expansion of Medical Scenarios: It is applicable to sleep centers, respiratory departments, cardiology departments, neurology departments, primary medical institutions, and health management scenarios, promoting the sinking of high-quality medical resources and the implementation of the hierarchical medical system.


     The technology dramatically enhances the efficiency of early screening for sleep disorders and provides an intelligent, continuous solution for home health management and remote diagnosis, offering profound clinical and social value.


NCC MEDICAL: A Track Record of Innovation and Authority Recognition


     NCC MEDICAL has a long-standing commitment to the R&D and commercialization of intelligent medical devices. Leveraging its deep expertise in sensor technology, embedded systems, and AI algorithms, the company continues to drive innovation across Smart Healthcare, Chronic Disease Management, and Rehabilitation Care.


     Inclusion in this top-tier national program is a definitive validation of NCC MEDICAL CORP. LTD.'s technological innovation capabilities and its potential for industrial transformation within the field of AI medical devices, affirmed by China's highest regulatory and industrial authorities.


     Looking forward, NCC MEDICAL is dedicated to deepening its technological development and clinical partnerships. The company will expedite the optimization, upgrade, and regulatory certification of its Smart Sleep Monitoring System, aiming for swift market application to contribute to a more precise, efficient, and accessible smart healthcare ecosystem globally.



About NCC Medical Co.,Ltd


     For 28 years, NCC Medical has focused on tackling key challenges in electrophysiological technology and developing related products. Adhering to the core value of "Commitment,Sincerity,Integrity," the company has continuously launched high-end electrophysiological equipment with independent intellectual property rights, driving the development of the electrophysiology industry. Its independently developed product—the first domestically made neurostimulation monitor specifically designed for intraoperative use in orthopedics and neurosurgery—has achieved a major breakthrough in domestic manufacturing and broken the barrier of reliance on imported equipment. Looking ahead, in the field of intraoperative electrophysiology, NCC Medical aims to strengthen industry-academia-research cooperation with clinical institutions, advance the development of cutting-edge technologies in this field, and provide higher-quality services for patients.




     As a "National-level Specialized, Refined, Differential, and Innovative Little Giant Enterprise" recognized by the Ministry of Industry and Information Technology, NCC Medical has always adhered to independent innovation and lean manufacturing, and built a full-chain independent and controllable system covering core technology R&D to key component production. The company's consumables subsidiary, Shanghai Yingshou Medical Device Co., Ltd., has also been awarded the title of "Shanghai Municipal-level Specialized, Refined, Differential, and Innovative Little Giant Enterprise", which further strengthens the company's leading advantages in the collaborative innovation of equipment and consumables.




     NCC Medical attaches great importance to technological innovation and clinical value. Its independently developed intraoperative  neuromonitoring and 256 high-channel event-related potential digital EEG capable of assisting cognitive diagnosis have both been included in the Shanghai Innovative Medical Devices Catalog . This marks that the products have obtained authoritative recognition in terms of technological advancement, clinical urgency, and quality and safety standards.






label: